RE: Liberum research note23 Jan 2024 16:26
A relief we went up. Some pretty mixed figures in TU, some of which make little sense. Massive cash outflow (short term) in hedging costs - explains the cautious interim dividend, but at odds with PR's comments in the IM presentation in response to a direct question on that very issue. But looking at cash figures, I get EBITDA for 2023 roughly £40m. Hence, on £450 - £455m revenue margins up (GP% up a tad, bad debts % down).
As contracts are 1 - 2 years, I think those margins are locked in for 2024 - prices fixed and hedged, so not sure margins will fall back until 2025. Bookings into 2025 look like at the £300m mark, which means this is all two year plus contracts. I can't reconcile this with the £519m for 2024, 2025 is too high, or 2024 is too low!
With a much bigger proportion of two year contracts, renewals in 2024 will be lower, leading to a fall in average monthly bookings, exacerbated by the falling prices. The turbulence in w/s markets and shifting renewal patterns is making this very difficult to forecast. SP Angel say their forecasts are conservative at £665m revenue. I am unable to justify a higher figure at this stage now.
SP Angels note is just plain weird - not separating out the bad debs, what's the £8m non-recurring costs?
Any one with the Liberum note - could you post up the 2024 forecasts in plain English - revenue, gp%, bad debt %, general overheads? A 1,000 thanks.
Got the 170p eps though by the looks of it / Brokers notes. Can't judge where the market will now rate us now. It's provided clarity that this is the profit and it's sustainable, though growth in customers will be mooted by falling prices going forwards. So not a growth rating, but one of confidence in decent profits and margins - the market will decide!
Once the collateral reverses out, and normalises, looking like sensible dividends will be paid - once confirmed, should also help the market price. Hopefully trend upwards now, slowly, not expecting a 'break-out'.